Skip to main content
Log in

Current status of surgical treatment of Boerhaave’s syndrome

  • Original Article
  • Published:
Esophagus Aims and scope Submit manuscript

Abstract

Background

Surgical treatment is usually required for Boerhaave’s syndrome (post-emetic esophageal perforation), and the technique should be chosen based on the local infection status and patient’s general condition. This study was performed to examine the current status of surgical treatment of Boerhaave’s syndrome in Japan.

Methods

Ninety-five patients with Boerhaave’s syndrome who underwent surgical treatment from January 2010 to December 2015, obtained from a national survey were retrospectively analyzed. The details of each surgical treatment and the type of treatment performed according to the patients’ characteristics were examined.

Results

Primary closure was performed in 75 (78.9%) patients, T-tube insertion in 15 (15.8%), and esophagectomy in 5 (5.3%). The length of the postoperative stay was significantly shorter in patients who underwent primary closure (p = 0.0011). Esophagectomy tended to be performed more often in patients with a long perforation and was performed significantly more often in patients with a high C-reactive protein concentration (p = 0.0118). The postoperative hospital stay was significantly longer in patients with leakage of the primary closure site (p < 0.0001). As a result, leakage of the primary closure site was significantly correlated with a long duration from symptom onset to patient presentation (p = 0.042), diagnostic imaging of the intrathoracic perforation (p = 0.013), and abscess formation in the mediastinal cavity (p = 0.006).

Conclusions

Selection of an appropriate surgical procedure may contribute to reduced mortality rates in patients with esophageal rupture. With regard to primary closure, it is necessary to understand that leaks are likely to occur in patients with a long duration from symptom onset to presentation or with severe intrathoracic/mediastinal inflammation, and to select an appropriate surgical procedure in consideration of the degree of invasiveness and QOL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Sohda M, Kuwano H, Sakai M, et al. A national survey on esophageal perforation: study of cases at accredited institutions by the Japanese Esophagus Society. Esophagus. 2020;17:230–8.

    Article  PubMed  Google Scholar 

  2. Sohda M, Saeki H, Kuwano H, et al. Clinical features of idiopathic esophageal perforation compared with typical post-emetic type: a newly proposed subtype in Boerhaave’s syndrome. Esophagus. 2021. https://doi.org/10.1007/s10388-020-00802-0.

    Article  PubMed  Google Scholar 

  3. Markar SR, Mackenzie H, Wiggins T, et al. Management and outcomes of esophageal perforation: a national study of 2564 patients in England. Am J Gastroenterol. 2015;110:1559–66.

    Article  PubMed  Google Scholar 

  4. Pezzetta E, Kokudo T, Uldry E, et al. The surgical management of spontaneous esophageal perforation (Boerhaave’s syndrome)—20 years of experience. Biosci Trends. 2016;10:120–4.

    Article  PubMed  Google Scholar 

  5. Janjua KJ. Boerhaave’s syndrome. Postgrad Med J. 1997;73:265–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Bufkin BL, Miller JI Jr, Mansour KA. Esophageal perforation: emphasis on management. Ann Thorac Surg. 1996;61:1447–51 (discussion 1451–2).

    Article  CAS  PubMed  Google Scholar 

  7. Waltersten M, Sundbom M. Patient-reported long-term outcome is superior after treatment with self-expanding metallic stents in esophageal perforations. Scand J Surg. 2020. https://doi.org/10.1177/1457496920960999.

    Article  PubMed  Google Scholar 

  8. Brinster CJ, Singhal S, Lee L, et al. Evolving options in the management of esophageal perforation. Ann Thorac Surg. 2004;77:1475–83.

    Article  PubMed  Google Scholar 

  9. Okamoto H, Onodera K, Kamba R, et al. Treatment of spontaneous esophageal rupture (Boerhaave’ syndrome) using thoracoscopic surgery and sivelestat sodium hydrate. J Thorac Dis. 2018;10:2206–12.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kollmar O, Lindemann W, Richter S, et al. Boerhaave’s syndrome: primary repair vs. esophageal resection–case reports and meta-analysis of the literature. J Gastrointest Surg. 2003;7:726–34.

    Article  PubMed  Google Scholar 

  11. Haveman JW, Nieuwenhuijs VB, Kobold JP, et al. Adequate debridement and drainage of the mediastinum using open thoracotomy or video-assisted thoracoscopic surgery for Boerhaave’s syndrome. Surg Endosc. 2011;25:2492–7.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sakamoto Y, Tanaka N, Furuya T, et al. Surgical management of late esophageal perforation. Thorac Cardiovasc Surg. 1997;45:269–72.

    Article  CAS  PubMed  Google Scholar 

  13. Wright CD, Mathisen DJ, Wain JC, et al. Reinforced primary repair of thoracic esophageal perforation. Thorac Surg. 1995;60:245–8 (discussion 248–9).

    Article  CAS  Google Scholar 

  14. Aiolfi A, Micheletto G, Guerrazzi G, et al. Minimally invasive surgical management of Boerhaave’s syndrome: a narrative literature review. J Thorac Dis. 2020;12:4411–7.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hayakawa S, Mitsui A, Kato Y, et al. Laparoscopic transhiatal suture closure for spontaneous esophageal rupture: a case report. Surg Case Rep. 2019;5:149.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the individuals at each participating facility (Supplemental Table 2) who responded to our questionnaire survey. We also thank Angela Morben, DVM, ELS, from Edanz Group (https://en-author-services.edanz.com/ac), for editing a draft of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Makoto Sohda.

Ethics declarations

Conflict of interest

Makoto Sohda, Hiroshi Saeki, Hiroyuki Kuwano, Makoto Sakai, Akihiko Sano, Takehiko Yokobori, Tatsuya Miyazaki, Yoshihiro Kakeji, Yasushi Toh, Yuichiro Doki, and Hisahiro Matsubara declare that they have no conflict of interest.

Ethical Statement

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 155 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sohda, M., Saeki, H., Kuwano, H. et al. Current status of surgical treatment of Boerhaave’s syndrome. Esophagus 19, 175–181 (2022). https://doi.org/10.1007/s10388-021-00858-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10388-021-00858-6

Keywords

Navigation